| Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | |
|---|---|---|---|---|---|---|
CASH FLOWS FROM OPERATING ACTIVITIES: | ||||||
Net income | ||||||
2,224 | 3,103 | 4,551 | -2,512 | 21,363 | 64,931 | |
Adjustments to reconcile net income to net cash provided by operating activities: | ||||||
Deferred compensation | ||||||
2,051 | 1,714 | 1,550 | 2,234 | 798 | 1,361 | |
Depreciation and amortization | ||||||
8,353 | 7,469 | 6,908 | 6,279 | 8,213 | 9,205 | |
Write-off of debt issuance costs | ||||||
- | - | 0 | 2,165 | 282 | 696 | |
Amortization of deferred debt issuance costs and discounts | ||||||
88 | 101 | 44 | 428 | 204 | 334 | |
Gain on condemnation of Valencia | ||||||
- | - | - | - | 42,983 | - | |
Gain on sale of Loop 303 contracts | ||||||
-1,000 | 0 | - | - | 296 | - | |
Loss on sale of Willow Valley | ||||||
- | - | 0 | 54 | 176 | - | |
Loss on equity investment | ||||||
-79 | -265 | -136 | -340 | -329 | 144 | |
Gains on regulatory order | ||||||
- | - | - | - | - | 50,664 | |
Other (gains) and losses | ||||||
-5 | 27 | 0 | 978 | 0 | 50 | |
Provision for doubtful accounts receivable | ||||||
50 | 93 | 128 | 70 | 69 | 83 | |
Deferred income tax expense | ||||||
570 | 1,236 | 529 | -1,408 | 20,561 | -16,995 | |
Changes in assets and liabilities | ||||||
Accounts receivable | ||||||
193 | -178 | 179 | 409 | -125 | -26 | |
Other current assets | ||||||
60 | 110 | 116 | 415 | 2,241 | 0 | |
Accounts payable and other current liabilities | ||||||
-1,584 | -688 | -1,247 | -4,087 | -2,502 | -227 | |
Other noncurrent assets | ||||||
-75 | -73 | 1,763 | -117 | -147 | -34 | |
Other noncurrent liabilities | ||||||
908 | -2,100 | 615 | 17 | 0 | 3,056 | |
Net cash provided by operating activities | ||||||
11,566 | 11,307 | 11,156 | 1,895 | 4,245 | 11,646 | |
CASH FLOWS FROM INVESTING ACTIVITIES: | ||||||
Capital expenditures | ||||||
11,187 | 4,787 | 20,885 | 8,588 | 3,355 | 1,655 | |
Payments for (Proceeds from) Previous Acquisition | ||||||
0 | -8,475 | 0 | - | - | - | |
Proceeds from the condemnation of Valencia | ||||||
- | - | - | - | 55,107 | - | |
Cash received from the sale of Loop 303 contracts | ||||||
- | - | - | - | 296 | - | |
Cash advance to related party | ||||||
- | - | - | - | 12,745 | - | |
Repayment of related party cash advance | ||||||
- | - | - | - | 12,745 | - | |
Proceeds from the sale of Willow Valley | ||||||
1,000 | 0 | 0 | 2,254 | 0 | - | |
Deposits of restricted cash, net | ||||||
- | - | 208 | -154 | 70 | -198 | |
Other cash flows from investing activities | ||||||
-131 | 58 | -95 | -13 | 6 | -26 | |
Net cash used in investing activities | ||||||
-10,056 | -13,320 | -20,998 | -6,167 | 51,972 | -1,431 | |
CASH FLOWS FROM FINANCING ACTIVITIES: | ||||||
Dividends paid | ||||||
6,165 | 5,791 | 5,399 | 5,036 | 27,607 | 3,454 | |
Advances in aid of construction | ||||||
1,199 | 817 | 574 | 346 | 357 | 365 | |
Proceeds from stock option exercise | ||||||
414 | 790 | 375 | 0 | 0 | - | |
Principal payments under capital lease | ||||||
64 | 27 | 79 | 378 | 99 | 105 | |
Refunds of advances for construction | ||||||
952 | 896 | 854 | 794 | 975 | 747 | |
Loan borrowings | ||||||
35 | 140 | 0 | 115,000 | 0 | 21,800 | |
Loan repayments | ||||||
39 | 9 | 5 | 0 | 21,719 | 10,390 | |
Repayments of bond debt | ||||||
- | - | 0 | 106,695 | 1,775 | 12,347 | |
Deposits in bond service fund | ||||||
- | - | - | - | - | 1,000 | |
Proceeds withdrawn from bond service fund | ||||||
- | - | 0 | 8,825 | 1,001 | 626 | |
Proceeds from sale of stock | ||||||
0 | 15,910 | 0 | 8,372 | 0 | - | |
Share repurchase | ||||||
- | - | - | - | 464 | - | |
Payment of Sonoran acquisition liability | ||||||
- | - | 0 | 2,800 | 0 | - | |
Debt issuance costs paid | ||||||
40 | 134 | 20 | 760 | 0 | 346 | |
Payments of offering costs for sale of stock | ||||||
0 | 1,274 | 0 | 2,823 | 0 | - | |
Net cash (used) provided by financing activities | ||||||
-5,612 | 9,526 | -5,408 | 13,257 | -51,281 | -5,598 | |
INCREASE IN CASH, CASH EQUIVALENTS, AND RESTRICTED CASH | ||||||
- | - | -15,250 | 8,985 | 4,936 | 4,617 | |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect [Abstract] | ||||||
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Abstract] | ||||||
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | ||||||
-4,102 | 7,513 | - | - | - | - | |